Current Scientific and Regulatory Approaches for Development of Orally Inhaled and Nasal Drug Products: Overview of the IPAC-RS/University of Florida Orlando Inhalation Conference

AAPS Journal

Volumn 17, Issue 5, 2015, Pages 1305-1311

  Hochhaus, Guenther ^a   Davis Cutting, Craig ^b   Oliver, Martin ^c   Lee, Sau L ^d   Lyapustina, Svetlana ^e,f  

^a UNIVERSITY OF FLORIDA   (United States)

^b CATALENT PHARMA SOLUTIONS   (United States)

^c VECTURA GROUP PLC   (United Kingdom)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e Pharmaceutical Practice Group DBR   (United States)

^f Drinker Biddle and Reath LLP   (United States)

Author keywords

bioequivalence; emerging markets; generics; MDIs and DPIs; regulatory science

Indexed keywords

GENERIC DRUG; DRUG;

ARTICLE; BIOEQUIVALENCE; BRAZIL; CHINA; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRY POWDER INHALER; EUROPE; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HUMAN; INDIA; MEDICAL LITERATURE; MEDICAL RESEARCH; METERED DOSE INHALER; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; UNITED STATES; DRUG DESIGN; DRUG LEGISLATION; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; THERAPEUTIC EQUIVALENCE;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; DRUG DESIGN; DRUGS, GENERIC; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; THERAPEUTIC EQUIVALENCY;

EID: 84939566474     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-015-9791-z     Document Type: Article

References (10)

1. Lee SL, Saluja B, García-Arieta A, Santos GML, Li Y, Lu S, et al. Regulatory considerations for approval of generic inhalation drug products in the US, EU, Brazil, China, and India. AAPS J. 2015. doi:10.1208/s12248-015-9787-8.
2. Leiner S, Parkins D, Lastow O. Inhalation devices and patient interface: human factors. AAPS J. 2015;17(2): 457–461. doi: 10.1208/s12248-015-9717-9http://link.springer.com/article/10.1208/s12248-015-9717-9. Accessed 21 Jan 2015.
3. Forbes B, Bäckman P, Christopher D, Dolovich M, Li BV, Morgan B. In vitro testing for orally inhaled products: developments in science-based regulatory approaches. AAPS J. 2015. doi: 10.1208/s12248-015-9763-3. http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12248-015-9763-3. Accessed 19 May 2015.
4. Hochhaus G, Horhota S, Hendeles L, Suarez S, Rebello J. Pharmacokinetics of orally inhaled drug products. AAPS J. 2015. doi: 10.1208/s12248-015-9736-6. http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12248-015-9736-6. Accessed 15 April 2015.
5. Hendeles L, Daley-Yates PT, Hermann R, Backer J, Dissanayake S, Horhota ST. Pharmacodynamic studies to demonstrate bioequivalence of oral inhalation products. AAPS J. 2015; 17 (3): 758–768. doi: 10.1208/s12248-015-9735-7. http://link.springer.com/article/10.1208%2Fs12248-015-9735-7. Accessed 19 May 2015.
6. Weber B, Lee SL, Delvadia R, Lionberger R, Li BV, Tsong Y, Hochhaus G. Application of the modified chi-square ratio statistic in a stepwise procedure for cascade impactor equivalence testing. AAPS J. 2015; 17 (2): 370–379. doi: 10.1208/s12248-014-9698-0. http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12248-014-9698-0. Accessed 15 April 2015
7. Shur J, Saluja B, Lee S, Tibbatts J, Price R. Effect of device design and formulation on the in vitro comparability for multi-unit dose dry powder inhalers. AAPS J. May 2015. doi: 10.1208/s12248-015-9775-z. http://link.springer.com/article/10.1208/s12248-015-9775-z. Accessed 19 May 2015.
8. Horhota ST, Noord JA, Verkleij CB, Bour LJ, Sharma A, Trunk M, Cornelissen PJG. In vitro, pharmacokinetic, pharmacodynamic, and safety comparisons of single and combined administration of tiotropium and salmeterol in COPD patients using different dry powder inhalers. AAPS J. 2015. doi: 10.1208/s12248-015-9751-7. http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12248-015-9751-7. Accessed 15 April 2015.
9. Dissanayake SB. Safety of β2-agonists in asthma: linking mechanisms, meta-analyses and regulatory practice. AAPS J. 2015. doi: 10.1208/s12248-015-9734-8. http://www.pharmagateway.net/ArticlePage.aspx?DOI=10.1208/s12248-015-9734-8. Accessed 15 April 2015.
10. IPAC-RS and UF. Orlando Inhalation Conference: Approaches in International Regulation. 2014. http://www.cvent.com/events/orlando-inhalation-conference-approaches-in-international-regulation/agenda-8a749091c2c741228907ca5c70b619eb.aspx. Accessed 26 Nov 2014.